Angiogenesis in the Progression of Breast Ductal Proliferations

被引:13
作者
Carpenter, Philip M. [1 ,2 ]
Chen, Wen-Pin [2 ]
Mendez, Aaron
McLaren, Christine E. [3 ]
Su, Min-Ying [4 ]
机构
[1] Univ Calif Irvine, Irvine Med Ctr, Dept Pathol & Lab Med, Orange, CA 92868 USA
[2] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92868 USA
[3] Univ Calif Irvine, Dept Epidemiol, Orange, CA 92868 USA
[4] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Orange, CA 92868 USA
关键词
breast; angiogenesis; hyperplasia; ductal carcinoma in situ; CD31; CD105; vascular endothelial growth factor; microvessel density; CARCINOMA IN-SITU; MICROVESSEL DENSITY; VASCULAR DENSITY; EXPRESSION; CANCER; CD105; LESIONS; MARKERS; PATTERNS; ENDOGLIN;
D O I
10.1177/1066896909333511
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Angiogenesis, the formation of blood vessels, is necessary for a tumor to grow, but when angiogenesis first appears in the progression of breast ductal carcinomas is unknown. To determine when this occurs, the authors examined microvessel density (MVD) by CD31 and CD105 immunostaining in normal ducts, 32 cases of usual hyperplasia, 19 cases of atypical hyperplasia, and 29 cases of ductal carcinoma in situ (DCIS). Simple hyperplasia had a 22-fold greater MVD than normal ducts (P < .0001). An increase during the progression of ductal changes was highly significant (P < .0001). To determine a possible mechanism, immunohistochemistry for vascular endothelial growth factor (VEGF) was evaluated. VEGF staining intensity of ductal epithelium increased during the progression from normal to hyperplastic to DCIS. This study shows that the first significant increase in angiogenesis occurs very early in the evolution of ductal proliferations as ductal cells become hyperplastic.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 42 条
  • [1] Lack of specificity of endoglin expression for tumor blood vessels
    Balza, E
    Castellani, P
    Zulstra, A
    Neri, D
    Zardi, L
    Siri, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (04) : 579 - 585
  • [2] Bodey B, 1998, ANTICANCER RES, V18, P3621
  • [3] How tumors become angiogenic
    Bouck, N
    Stellmach, V
    Hsu, SC
    [J]. ADVANCES IN CANCER RESEARCH, VOL 69, 1996, 69 : 135 - 174
  • [4] Brown LF, 1999, CLIN CANCER RES, V5, P1041
  • [5] Cao Y, 2004, ARCH PATHOL LAB MED, V128, P893
  • [6] Long-term prognostic significance of neoangiogenesis in breast carcinomas: Comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression
    Dales, JP
    Garcia, S
    Carpentier, S
    Andrac, L
    Ramuz, O
    Lavaut, MN
    Allasia, C
    Bonnier, P
    Charpin, C
    [J]. HUMAN PATHOLOGY, 2004, 35 (02) : 176 - 183
  • [7] CD105 is important for angiogenesis: evidence and potential applications
    Duff, SE
    Li, CG
    Garland, JM
    Kumar, S
    [J]. FASEB JOURNAL, 2003, 17 (09) : 984 - 992
  • [8] Engels K, 1997, J PATHOL, V181, P207
  • [9] Engels K, 1997, J PATHOL, V182, P414, DOI 10.1002/(SICI)1096-9896(199708)182:4<414::AID-PATH897>3.0.CO
  • [10] 2-Q